The progress of glucocorticoids via postauricular injection in treatment of sudden hearing loss
-
Abstract: Corticosteroids are commonly accepted and recommended for treating sudden hearing loss.In recent years,postauricular delivery attracts attention due to the advantage of high drug concentration in cochlear and minimal side-effects.This article reviews the published literature related the application of glucocorticoids via postauricular injection in treatment of sudden hearing loss and its animal experiments,speculates the possible pathway that drugs enter inner ear,and put forward the idea of treating facial nerve diseases via postauricular injection.
-
Key words:
- hearing loss /
- sudden /
- glucocorticoids /
- postauricular
-
-
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会.突发性聋诊断和治疗指南(2015).中华耳鼻咽喉头颈外科杂志,2015,50(6):443-447.
[2] 中国突发性聋多中心临床研究协作组.中国突发性聋分型治疗的多中心临床研究[J].中华耳鼻咽喉头颈外科杂志,2013,48(5):355-361.
[3] HAYNES D S,O'MALLEY M,COHEN S,et al.Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy[J].Laryngoscope,2007,117:3-15.
[4] CONLIN A E,PARNES L S.Treatment of sudden sensorineural hearing loss:I.A systematic review[J].Arch Otolaryngol Head Neck Surg,2007,133:573-581.
[5] PENIDO NDE O,RAMOS H V,BARROS F A,et al.Clinical,etiological and progression factors of hearing in sudden deafness[J].Braz J Otorhinolaryngol,2005,71:633-638.
[6] RAREY K E,CURTIS L M.Receptors for glucocorticoids in the human inner ear[J].Otolaryngol Head Neck Surg,1996,115:38-41.
[7] GARCIA BERROCAL J R,RAMIREZ-CAMACHOR.Immune response and immunopathology of the inner ear:an update[J].J Laryngol Otol,2000,114:101-107.
[8] KANZAKI S,FUJIOKA M,YASUDA A,et al.Novel in vivo imaging analysis of an inner ear drug delivery system in mice:comparison of inner ear drug concentrations over time after transtympanic and systemic injections[J].PLoS One,2012,7:480-484.
[9] LUO J,XU L.Distribution of gentamicin in inner ear after local administration via a chitosan glycerophosphate hydrogel delivery system[J].Ann Otol Rhinol Laryngol,2012,121:208-216.
[10] 杨晓琦,余力生,马鑫.耳后注射复方倍他米松治疗顽固性低频型感音神经性聋[J].中华耳鼻咽喉头颈外科杂志,2007,42(11):814-816.
[11] LI X,ZHANG X Y,WANG Q J,et al.Efficacy of methylprednisolone sodium succinate for injection(postotic injection)on the auditory threshold and speech recognition rate of sudden deafness patients[J].Int J Clin Exp Med,2015,8:14110-14114.
[12] 王明明.糖皮质激素局部注射与全身应用在特发性突发性聋分型治疗中的疗效[J].中华耳鼻咽喉头颈外科杂志,2014,49(1):11-15.
[13] 吴思恩,李清明,黄素红.耳后注射甲基泼尼松龙治疗低中频下降型突发性聋的疗效观察[J].临床耳鼻咽喉头颈外科杂志,2015,29(10):928-930.
[14] 王翡,刘雪梅.耳后给药治疗中高频下降型突发性聋的疗效分析[J].临床耳鼻咽喉头颈外科杂志,2015,29(4):359-361.
[15] 赵群.耳后注射甲强龙对全聋型突发性聋疗效分析[J].中国听力语言康复科学杂志,2015,4(4):295-297.
[16] 静媛媛,余力生,马鑫,等.耳后注射甲强龙治疗难治性突发性聋疗效分析[J].中华耳科学杂志,2014,17(3):452-454.
[17] 兰龙江,徐珏.乳突筛区骨膜下注射甲泼尼龙琥珀酸钠治疗常规治疗失败的突发性聋[J].中国耳鼻咽喉头颈外科,2014,21(6):287-289.
[18] 郑亿庆.低中频下降型突发性聋药物治疗的多中心研究[J].中华耳鼻咽喉头颈外科杂志,2013,48(5):362-367.
[19] 林运娟.大鼠耳后和肌肉注射地塞米松后内耳组织药物浓度分析[J].中国耳鼻咽喉头颈外科,2009,16(7):381-384.
[20] LI J,YU L,XIA R,et al.Postauricular hypodermic injection to treat inner ear disorders:experimental feasibility study using magnetic resonance imaging and pharmacokinetic comparison[J].J Laryngol Otol,2013,127:239-245.
[21] 静媛媛.耳后注射复方倍他米松豚鼠血浆中药代动力学特征[J].听力学及言语疾病杂志,2009,17(4):354-357.
[22] 王君玉.经乳突乙状窦入路手术及其相关的应用解剖[J].解剖与临床,2007,12(2):79-81.
[23] 余力生.内淋巴囊的脉管分布[J].临床耳鼻咽喉科杂志,1999,13(1):26-27.
[24] FRIIS M,QVORTRUP K.A potential portal flow in the inner ear[J].Laryngoscope,2007,117:194-198.
[25] GADRE A K,FAYAD J N,O'LEARY M J,et al.Arterial supply of the human endolymphatic duct and sac[J].Otolaryngol Head Neck Surg,1993,108:141-148.
[26] 张为龙,钟世镇.临床解剖学丛书(头颈部分册)[M].北京:人民卫生出版社,1994:344-344.
[27] 狄国华.利多卡因联合天麻素耳后注射治疗特发性耳鸣[J].山东大学耳鼻喉眼学报,2015,6(6):5-7.
[28] 崔晓颖.耳后注射神经生长因子治疗老年性聋的效果分析[J].中国当代医药,2015,26(26):116-118.
[29] 刘辉.耳后注射神经生长因子治疗老年性聋临床分析[J].河北医药,2011,33(22):3421-3422.
-
计量
- 文章访问数: 153
- PDF下载数: 94
- 施引文献: 0
下载: